Next Article in Journal
From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis
Next Article in Special Issue
Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
Previous Article in Journal
Percutaneous Irreversible Electroporation for Treatment of Small Hepatocellular Carcinoma Invisible on Unenhanced CT: A Novel Combined Strategy with Prior Transarterial Tumor Marking
Previous Article in Special Issue
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy
 
 
Article

Article Versions Notes

Cancers 2021, 13(9), 2022; https://doi.org/10.3390/cancers13092022
Action Date Notes Link
article xml file uploaded 22 April 2021 11:59 CEST Original file -
article xml uploaded. 22 April 2021 11:59 CEST Update -
article pdf uploaded. 22 April 2021 11:59 CEST Version of Record https://www.mdpi.com/2072-6694/13/9/2022/pdf-vor
article supplementary file uploaded. 22 April 2021 11:59 CEST - https://www.mdpi.com/2072-6694/13/9/2022#supplementary
article html file updated 22 April 2021 12:00 CEST Original file -
article xml file uploaded 25 April 2021 12:54 CEST Update -
article xml uploaded. 25 April 2021 12:54 CEST Update https://www.mdpi.com/2072-6694/13/9/2022/xml
article pdf uploaded. 25 April 2021 12:54 CEST Updated version of record https://www.mdpi.com/2072-6694/13/9/2022/pdf
article html file updated 25 April 2021 12:55 CEST Update -
article html file updated 25 July 2022 13:24 CEST Update https://www.mdpi.com/2072-6694/13/9/2022/html
Back to TopTop